$KPTI
Karyopharm Therapeutics Inc.

2015 Q1 Form 10-K Financial Statement

#000119312515091264 Filed on March 13, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 2013 Q4
Revenue $0.00 $229.0K $21.00K
YoY Change -100.0% -40.83% -36.36%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.400M $15.90M $2.480M
YoY Change 86.21% 169.49% 306.56%
% of Gross Profit
Research & Development $20.75M $60.13M $9.690M
YoY Change 89.01% 111.33% 164.03%
% of Gross Profit
Depreciation & Amortization $140.0K $320.0K $30.00K
YoY Change 250.0% 122.22% 0.0%
% of Gross Profit
Operating Expenses $26.15M $76.08M $12.17M
YoY Change 88.36% 121.55% 184.92%
Operating Profit -$26.15M -$75.85M -$12.15M
YoY Change 90.71% 123.41% 186.64%
Interest Expense $140.0K $1.000K $0.00
YoY Change 600.0%
% of Operating Profit
Other Income/Expense, Net $83.00K $69.00K $2.000K
YoY Change 361.11% 2200.0%
Pretax Income -$26.07M -$75.78M -$12.15M
YoY Change 90.43% 123.53% 186.56%
Income Tax -$75.78M $0.00
% Of Pretax Income
Net Earnings -$26.07M -$75.78M -$12.15M
YoY Change 90.35% 123.22% 186.56%
Net Earnings / Revenue -33090.39% -57857.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$738.1K -$2.437M -$710.9K
COMMON SHARES
Basic Shares Outstanding 35.68M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $246.4M $205.7M $156.0M
YoY Change 70.05% 31.86%
Cash & Equivalents $51.45M $150.6M $156.0M
Short-Term Investments $195.0M $55.10M
Other Short-Term Assets $2.900M $2.000M $2.000M
YoY Change 7.41% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $249.3M $207.8M $158.0M
YoY Change 68.95% 31.52% 16457.23%
LONG-TERM ASSETS
Property, Plant & Equipment $3.282M $2.800M $240.0K
YoY Change 919.25% 1300.0% -26.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $38.50M $8.700M
YoY Change
Other Assets $500.0K $1.200M $30.00K
YoY Change -49.85% 0.0%
Total Long-Term Assets $42.72M $12.50M $270.0K
YoY Change 2385.22% 6150.0% -24.37%
TOTAL ASSETS
Total Short-Term Assets $249.3M $207.8M $158.0M
Total Long-Term Assets $42.72M $12.50M $270.0K
Total Assets $292.0M $220.3M $158.2M
YoY Change 95.63% 39.25% 11969.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.957M $6.300M $1.740M
YoY Change 112.56% 270.59% 61.71%
Accrued Expenses $7.417M $5.800M $1.168M
YoY Change 378.52% 383.33% 52.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.70M $12.30M $3.292M
YoY Change 193.16% 272.73% 70.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.800M $1.200M
YoY Change 958.82%
Total Long-Term Liabilities $1.800M $1.200M $0.00
YoY Change 958.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.70M $12.30M $3.292M
Total Long-Term Liabilities $1.800M $1.200M $0.00
Total Liabilities $16.52M $13.50M $3.292M
YoY Change 218.51% 309.09%
SHAREHOLDERS EQUITY
Retained Earnings -$164.4M -$62.57M
YoY Change
Common Stock $439.9M $3.000K
YoY Change 14663833.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $275.5M $206.8M $154.9M
YoY Change
Total Liabilities & Shareholders Equity $292.0M $220.3M $158.2M
YoY Change 95.63% 39.25% 11969.11%

Cashflow Statement

Concept 2015 Q1 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$26.07M -$75.78M -$12.15M
YoY Change 90.35% 123.22% 186.56%
Depreciation, Depletion And Amortization $140.0K $320.0K $30.00K
YoY Change 250.0% 122.22% 0.0%
Cash From Operating Activities -$20.23M -$51.45M -$10.08M
YoY Change 91.39% 69.86% 153.27%
INVESTING ACTIVITIES
Capital Expenditures $178.0K $2.834M -$30.00K
YoY Change 42.4% 4871.93%
Acquisitions
YoY Change
Other Investing Activities -$169.9M -$64.20M
YoY Change 42375.0%
Cash From Investing Activities -$170.1M -$67.03M -$30.00K
YoY Change 31990.57% 111616.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $90.99M $112.8M
YoY Change -0.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 91.16M 113.1M 113.2M
YoY Change 911500.0% -39.16% 4426.4%
NET CHANGE
Cash From Operating Activities -20.23M -51.45M -10.08M
Cash From Investing Activities -170.1M -67.03M -30.00K
Cash From Financing Activities 91.16M 113.1M 113.2M
Net Change In Cash -99.15M -5.360M 103.1M
YoY Change 794.05% -103.45% -7062.84%
FREE CASH FLOW
Cash From Operating Activities -$20.23M -$51.45M -$10.08M
Capital Expenditures $178.0K $2.834M -$30.00K
Free Cash Flow -$20.41M -$54.28M -$10.05M
YoY Change 90.82% 78.88% 152.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
3681 sqft
CY2014Q4 kpti Operating Lease Scheduled Rent Payments Due
OperatingLeaseScheduledRentPaymentsDue
374000
CY2014Q4 kpti Operating Lease Scheduled Rent Payments Due
OperatingLeaseScheduledRentPaymentsDue
455000
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
35682760 shares
CY2014Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29933 sqft
CY2014Q1 us-gaap Security Deposit
SecurityDeposit
400000
CY2014Q1 kpti Security Deposit Which May Be Reduced In Future
SecurityDepositWhichMayBeReducedInFuture
200000
CY2014Q2 dei Entity Public Float
EntityPublicFloat
580370783
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-12651000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6512000
CY2011Q4 kpti Revenue Recognition Milestone Method Number Of Research Agreements
RevenueRecognitionMilestoneMethodNumberOfResearchAgreements
2 Agreement
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-27877000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
391000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29587258 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29587258 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
305000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
25096000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
350000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3292000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1740000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62569000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1168000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
154934000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
155000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158226000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217500000
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
215000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
79000
CY2013Q4 us-gaap Liabilities
Liabilities
3292000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
100000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
155974000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
240000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
25096000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1982000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2731000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2670000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
590000
CY2013Q4 us-gaap Assets
Assets
158226000
CY2013Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
155765000
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
157956000
CY2013Q4 kpti Liability For Uncertain Tax Positions Current And Noncurrent
LiabilityForUncertainTaxPositionsCurrentAndNoncurrent
0
CY2013Q4 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
698000
CY2013Q4 kpti Deferred Tax Assets Operating Loss Carryforwards Domestic And State And Local
DeferredTaxAssetsOperatingLossCarryforwardsDomesticAndStateAndLocal
17876000
CY2013Q4 kpti Deferred Tax Assets Tax Deferred Expense Reserves And Accruals And Other Temporary Differences
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAndOtherTemporaryDifferences
1819000
CY2013Q4 kpti Revenue Recognition Milestone Method Number Of Research Agreements
RevenueRecognitionMilestoneMethodNumberOfResearchAgreements
2 Agreement
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32699380 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32699380 shares
CY2014Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
11 Securities
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
0 Securities
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
62000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
56266000
CY2014Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
126000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
494000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3894000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12301000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
3000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6288000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-138346000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1435000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5825000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
206794000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
309000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10321000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1458000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1412000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
220337000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
345166000
CY2014Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
324000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1338000
CY2014Q4 us-gaap Liabilities
Liabilities
13543000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1568000
CY2014Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1242000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
784000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
150609000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2754000
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
192982000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
63773000
CY2014Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
12635000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
56266000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2027000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
400000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
25000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4161000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6405000
CY2014Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
63773000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3248000
CY2014Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
4505000
CY2014Q4 us-gaap Long Term Investments
LongTermInvestments
8658000
CY2014Q4 us-gaap Assets
Assets
220337000
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
129209000
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
55115000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
63795000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
774000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
207751000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
55115000
CY2014Q4 kpti Liability For Uncertain Tax Positions Current And Noncurrent
LiabilityForUncertainTaxPositionsCurrentAndNoncurrent
0
CY2014Q4 kpti Operating Lease Property Leased Area Covered Under Amended Agreement
OperatingLeasePropertyLeasedAreaCoveredUnderAmendedAgreement
27701 sqft
CY2014Q4 kpti Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3624000
CY2014Q4 kpti Additional Area Included In Operating Sublease After Amendment
AdditionalAreaIncludedInOperatingSubleaseAfterAmendment
16234 sqft
CY2014Q4 kpti Deferred Tax Assets Operating Loss Carryforwards Domestic And State And Local
DeferredTaxAssetsOperatingLossCarryforwardsDomesticAndStateAndLocal
39970000
CY2014Q4 kpti Deferred Tax Assets Tax Deferred Expense Reserves And Accruals And Other Temporary Differences
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAndOtherTemporaryDifferences
1225000
CY2014Q4 kpti Share Based Compensation Arrangement By Share Based Payment Award Restricted Stock Exercise Of Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedStockExerciseOfOptionsNonvestedNumber
7148 shares
CY2014Q4 kpti Available For Sale Securities Debt Maturities After One Through Two Years
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYears
8658000
CY2014Q4 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P5Y
CY2014Q1 kpti Lessee Leasing Arrangements Operating Leases Additional Extension Term
LesseeLeasingArrangementsOperatingLeasesAdditionalExtensionTerm
P5Y
CY2014Q1 kpti Operating Leases Allowance For Improvements
OperatingLeasesAllowanceForImprovements
1616000
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.029 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.000 pure
CY2013 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
155583000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-30290000
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6067679 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.391 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.008 pure
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.59
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.039 pure
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
113155000
CY2013 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13300000
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
387000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1419000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
34000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-33950000
CY2013 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33947000
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
57000
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33947000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-33947000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
3000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3785000
CY2013 us-gaap Stock Issued1
StockIssued1
13980000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3785000
CY2013 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
200000
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
13000
CY2013 us-gaap Operating Expenses
OperatingExpenses
34337000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28452000
CY2013 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-23025000
CY2013 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
382000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-33947000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
174000
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
144000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
185930000
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
113155000
CY2013 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
99691000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-57000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5885000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
664000
CY2013 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
341000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
3785000
CY2013 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2013 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
91000
CY2013 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-10922000
CY2013 kpti Noncash Consulting Expense
NoncashConsultingExpense
88000
CY2013 kpti Proceeds From Sale Of Convertible Preferred Stock Net Of Issuance Costs
ProceedsFromSaleOfConvertiblePreferredStockNetOfIssuanceCosts
72434000
CY2013 kpti Stock Issued During Period Value Conversion Of Convertible Preferred Securities
StockIssuedDuringPeriodValueConversionOfConvertiblePreferredSecurities
99691000
CY2013 kpti Stock Issued During Period Value Conversion Of Special Participation Stock
StockIssuedDuringPeriodValueConversionOfSpecialParticipationStock
88000
CY2013 kpti Restricted Shares Common Stock Vested Value
RestrictedSharesCommonStockVestedValue
5000
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Registrant Name
EntityRegistrantName
KARYOPHARM THERAPEUTICS INC.
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2014 dei Trading Symbol
TradingSymbol
KPTI
CY2014 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.013 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.007 pure
CY2014 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-5365000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-51447000
CY2014 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segments
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1958210 shares
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b><i>Use of Estimates</i></b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p> <p style="MARGIN-BOTTOM: 0px; FONT-SIZE: 1px; MARGIN-TOP: 12px"> &#xA0;</p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 0pt; TEXT-INDENT: 4%"> On an ongoing basis, the Company&#x2019;s management evaluates its estimates, including estimates related to clinical trial accruals, <font style="WHITE-SPACE: nowrap">stock-based</font> compensation expense, and reported amounts of revenues and expenses during the reported period. The Company bases its estimates on historical experience and other <font style="WHITE-SPACE: nowrap">market-specific</font> or other relevant assumptions that it believes to be reasonable under the circumstances. Although the Company regularly assesses these estimates, actual results could differ from those estimates. Changes in estimates are recorded in the period in which they become known.</p> </div>
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
31135694 shares
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.411 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.028 pure
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001503802
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.43
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.014 pure
CY2014 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
284000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
45000
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-50000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-75846000
CY2014 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
27000
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
112837000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
305000
CY2014 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2014 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
52000
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
400000
CY2014 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-2000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
31200000
CY2014 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
63797000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
470000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
229000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-75806000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
69000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2834000
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-75777000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-75777000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
97000
CY2014 us-gaap Increase Decrease In Prepaid Rent
IncreaseDecreaseInPrepaidRent
-1368000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14240000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14240000
CY2014 us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
274000
CY2014 us-gaap Deferred Tax Expense From Stock Options Exercised
DeferredTaxExpenseFromStockOptionsExercised
3800000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-79000
CY2014 us-gaap Interest Expense
InterestExpense
1000
CY2014 us-gaap Operating Expenses
OperatingExpenses
76075000
CY2014 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
27000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60127000
CY2014 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-73439000
CY2014 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4445000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-76326000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
520000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
323000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
113121000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
112837000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-67031000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15948000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4496000
CY2014 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
284000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
14240000
CY2014 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2014 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
197000
CY2014 us-gaap Effect Of Exchange Rate On Cash Continuing Operations
EffectOfExchangeRateOnCashContinuingOperations
-8000
CY2014 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
-2887000
CY2014 kpti Operating Leases Allowance For Improvements
OperatingLeasesAllowanceForImprovements
1048000
CY2014 kpti Operating Loss And Tax Credit Carryforwards Limitations Period Over Which Cumulative Changes In Ownership Interest Of Significant Shareholders Considered
OperatingLossAndTaxCreditCarryforwardsLimitationsPeriodOverWhichCumulativeChangesInOwnershipInterestOfSignificantShareholdersConsidered
P3Y
CY2014 kpti Operating Loss And Tax Credit Carryforwards Limitations Threshold Percentage Of Cumulative Changes In Ownership Interest Of Significant Shareholders Considered
OperatingLossAndTaxCreditCarryforwardsLimitationsThresholdPercentageOfCumulativeChangesInOwnershipInterestOfSignificantShareholdersConsidered
0.50 pure
CY2014 kpti Royalty And Sublicense Payment
RoyaltyAndSublicensePayment
0
CY2014 kpti Restricted Shares Common Stock Vested Value
RestrictedSharesCommonStockVestedValue
305000
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.000 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.001 pure
CY2012 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-6121000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15509000
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.052 pure
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1775323 shares
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.391 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000 pure
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-8.95
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.000 pure
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
634000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
209000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-15890000
CY2012 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15888000
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
121000
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15888000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-15888000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
653000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
653000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-134000
CY2012 us-gaap Operating Expenses
OperatingExpenses
16524000
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
21000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-19744000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-121000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2429000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-66000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
653000
CY2012 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
49000
CY2012 kpti Proceeds From Sale Of Convertible Preferred Stock Net Of Issuance Costs
ProceedsFromSaleOfConvertiblePreferredStockNetOfIssuanceCosts
7500000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.52
CY2012 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
2000000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14095000
CY2012 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-15888000
CY2012 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
13000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15888000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
127000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
122000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
9509000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
233000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5611000
CY2013Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5611000
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
5844000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2014Q1 us-gaap Sales Revenue Net
SalesRevenueNet
171000
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-13712000
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13694000
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
13883000
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.86
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
133000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6870000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6869000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
7003000
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
CY2014Q2 us-gaap Sales Revenue Net
SalesRevenueNet
21000
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16448000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-16431000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
16469000
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.66
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9321000
CY2013Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9321000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
9321000
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19724000
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.79
CY2014Q4 us-gaap Sales Revenue Net
SalesRevenueNet
16000
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-25942000
CY2014Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14000
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25928000
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
25958000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
19765000
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2013Q4 us-gaap Sales Revenue Net
SalesRevenueNet
21000
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-12148000
CY2013Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12146000
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
12169000

Files In Submission

Name View Source Status
0001193125-15-091264-index-headers.html Edgar Link pending
0001193125-15-091264-index.html Edgar Link pending
0001193125-15-091264.txt Edgar Link pending
0001193125-15-091264-xbrl.zip Edgar Link pending
d824483d10k.htm Edgar Link pending
d824483dex1016.htm Edgar Link pending
d824483dex1017.htm Edgar Link pending
d824483dex1021.htm Edgar Link pending
d824483dex1022.htm Edgar Link pending
d824483dex211.htm Edgar Link pending
d824483dex231.htm Edgar Link pending
d824483dex232.htm Edgar Link pending
d824483dex311.htm Edgar Link pending
d824483dex312.htm Edgar Link pending
d824483dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g824483exa_pg001.jpg Edgar Link pending
g824483g21n65.jpg Edgar Link pending
g824483g47h15.jpg Edgar Link pending
g824483g81s44greyscale.jpg Edgar Link pending
g824483g96g59.jpg Edgar Link pending
kpti-20141231.xml Edgar Link completed
kpti-20141231.xsd Edgar Link pending
kpti-20141231_cal.xml Edgar Link unprocessable
kpti-20141231_def.xml Edgar Link unprocessable
kpti-20141231_lab.xml Edgar Link unprocessable
kpti-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending